Back to trial details

Intake questionnaire

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Applying to Trinity Health IHA Medical Group Hematology Oncology - Canton · Canton, Michigan

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Lung Non-Small Cell Carcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Canton for study visits?